Delivery Order SPE2DB20D2014-SPE2DB25FC50V
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,224.10 to AmerisourceBergen Drug Corp for the supply of Letrozole 2.5 mg tablets in a 90-count package. This competitive award, issued on August 11, 2025, with a completion date of August 12, 2025, represents a firm fixed price delivery order with no set-aside designation. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $1,033.38 to AmerisourceBergen Drug Corp for the supply of Letrozole 2.5 mg tablets in quantities of 90 units. This non-set-aside, firm fixed price delivery order was awarded on September 18, 2025, with an ultimate completion date of September 19, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $1,387.29 to AmerisourceBergen Drug Corp for the supply of Letrozole 2.5 mg tablets in a 30-count package. This competitive award, issued on September 10, 2025, with an ultimate completion date of September 11, 2025, represents a firm fixed-price delivery order with no set-aside designation. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, reflecting the company's role...
- The Defense Logistics Agency awarded a delivery order valued at $1,387.29 to AmerisourceBergen Drug Corp for the supply of Letrozole 2.5 mg tablets in quantities of 30, with a firm fixed price contract structure. The award was made on September 12, 2025, with an ultimate completion date of September 15, 2025, and represents a non-set-aside competitive procurement. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,906.52 to AmerisourceBergen Drug Corp for the supply of Letrozole 2.5 mg tablets (90-count units). This competitive award, issued on September 15, 2025, with an ultimate completion date of September 16, 2025, represents a firm fixed-price delivery order with no set-aside designation. The pharmaceutical product will be delivered to the Conshohocken, Pennsylvania location, which serves as AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Letrozole 2.5 mg tablets in quantities of 90 units at a firm fixed price of $1,271.50. This is a non-set-aside competitively awarded contract with an ultimate completion date of August 14, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a single transaction within AmerisourceBergen's...
- The Defense Logistics Agency awarded a $3,172.86 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Letrozole 2.5 mg tablets (90-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 29, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and represents a child delivery order under the company's larger...
- The Defense Logistics Agency (DLA) awarded a $1,145.15 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Letrozole 2.5 mg tablets in quantities of 30. The contract, which is a firm fixed price delivery order with no set-aside designation, is scheduled for completion by July 28, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award represents a competitive procurement action and reflects AmerisourceBergen's role as a...
- The Defense Logistics Agency awarded a $7,598.76 delivery order to AmerisourceBergen Drug Corp for 90 tablets of Letrozole 2.5 mg on September 16, 2025, with completion scheduled for September 17, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger pharmaceutical supply agreements. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Letrozole 2.5 mg tablets (90-count units) on August 19, 2025, with a ceiling value of $1,541.34 and firm fixed pricing. This non-set-aside, competitively awarded contract is classified as a delivery order with an ultimate completion date of August 20, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FC50VDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,081.74 to AmerisourceBergen Drug Corp for the supply of Letrozole 2.5 mg tablets (90-count units) under a firm fixed price contract. The award, issued on July 18, 2025, with an ultimate completion date of July 21, 2025, represents a non-competitive delivery order with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a leading pharmaceutical distributor serving federal medical procurement needs. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. This comprehensive IDC serves as a global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical commodities to support military healthcare programs worldwide. The company's federal contract portfolio demonstrates significant capability in delivering both brand-name and generic medications across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through this flexible contracting mechanism.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 7/18/25 |